Thesis
Lentiviral delivery of CRISPR Cas9 prime editing system for cystic fibrosis
- Abstract:
-
The field of gene editing is rapidly developing, particularly with advancements in gene editor technologies. Prime editing has been a significant breakthrough in gene editing, allowing precise, targeted correction of all types of DNA mutation, including insertion, deletion, and base substitutions, without inducing double strand breaks in the genome. Along with other gene editing tools based on the CRISPR-Cas9 technology, prime editing is being extensively researched for its potential to co...
Expand abstract
Actions
Access Document
- Files:
-
-
(Preview, Dissemination version, pdf, 8.5MB, Terms of use)
-
Authors
Contributors
+ Gill, D
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Radcliffe Department of Medicine
- Research group:
- Gill and Hyde Group: Gene Medicine Group
- Role:
- Supervisor
- ORCID:
- 0000-0002-5264-054X
+ Hyde, S
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Radcliffe Department of Medicine
- Research group:
- Gill and Hyde Group: Gene Medicine Group
- Role:
- Supervisor
+ Miah, K
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Radcliffe Department of Medicine
- Research group:
- Gill and Hyde Group: Gene Medicine Group
- Role:
- Supervisor
- ORCID:
- 0000-0002-3196-6612
- DOI:
- Type of award:
- DPhil
- Level of award:
- Doctoral
- Awarding institution:
- University of Oxford
- Language:
-
English
- Keywords:
- Subjects:
- Deposit date:
-
2025-03-03
- ARK identifier:
Terms of use
- Copyright holder:
- Dwiantari Satyapertiwi
- Copyright date:
- 2024
If you are the owner of this record, you can report an update to it here: Report update to this record